Navigation Links
Amsterdam Molecular Therapeutics (AMT) Holding N.V. (in liquidation) Announces Publication of its Accounts for 2011 and Notice of Annual General Meeting
Date:7/13/2012

AMSTERDAM, July 13, 2012 /PRNewswire/ --

Amsterdam Molecular Therapeutics (AMT) Holding NV (in liquidation) (Euronext: AMT) published its Annual Report and Accounts for the year ended December 31, 2011 and announced that it will host its Annual General Meeting at its headquarters (Meibergdreef 61, 1105 BA Amsterdam Zuidoost, the Netherlands) at 14.00 hrs on September 12, 2012. Shareholders of the dissolved company are invited to attend.

For further details, agenda and voting information, visit: http://www.amtbiopharma.com/investors/shareholder-information

About Amsterdam Molecular Therapeutics (AMT) Holding N.V. (in liquidation)

On March 30, 2012, an extraordinary general meeting of shareholders approved a major corporate restructuring and financing transaction involving the disposal of AMT's entire business and operations to uniQure B.V. and the subsequent dissolution, liquidation and delisting of AMT. On April 5, the disposal completed and AMT's dissolution as resolved by the extraordinary general meeting of shareholders became effective, with Mr. Jörn Aldag and Mr. Piers Morgan being appointed as the liquidators charged with the liquidation of the company's dissolved property. On April 26, 2012, the liquidators made an advance distribution - consisting of depositary receipts for ordinary class B in uniQure B.V. - to AMT's shareholders. There will not be any further (final) distributions made to AMT shareholders.

AMT and the AMT shares will continue to exist until the liquidation is finalised, which is expected to occur before the end of 2012. AMT and its shares ceasing to exist upon the ending of the liquidation shall effectively also result in the delisting of AMT, to the extent the delisting cannot be achieved at an earlier date in consultation with Euronext Amsterdam and subject to such conditions as Euronext Amsterdam may propose.

Furt
'/>"/>

SOURCE Amsterdam Molecular Therapeutics (AMT) B.V
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. EHA Honorary Awards at the 17th Congress of EHA in Amsterdam
2. joimax® at the Early Summer Congresses: SpineWeek Amsterdam and DGNC Leipzig
3. Blood Disorders: European Hematologists Gather in Amsterdam, June 14-17, 2012
4. BSGI Molecular Breast Imaging Proves Equivalent to MRI in Breast Cancer Patient Management
5. BSGI Molecular Breast Imaging Provides Better Results than MRI for Cancer Patients with Dense Breasts
6. The 2012 US Molecular Diagnostics Market
7. QIAGEN Unveils Initiative to Create Next-Generation Sequencing Portfolio for use in Clinical Research and Molecular Diagnostics
8. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
9. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
10. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
11. Echo Therapeutics Expands License Agreement with Ferndale Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 2015 UHC has released the findings of ... devices based on cost and quality outcomes to uncover ... The study examined utilization of PPIs—which can account for ... —at 10 academic medical centers, focusing on procedures utilizing ... The study, begun in 2013, integrated ...
(Date:3/31/2015)... and ORANGEBURG, N.Y., March 31, 2015 ... today announced the completion of their merger. The ... completion of the all-stock combination creates a new ... on April 1, 2015, Cogentix Medical, Inc. will ... Cogentix Medical will have its U.S. headquarters in ...
(Date:3/31/2015)... - Today, the Honourable Rona Ambrose, Minister of Health, met ... discuss the Government of Canada,s ... The roundtable provided an important opportunity for both human ... discuss roles and responsibilities in addressing AMR. Preserving the ... known as antimicrobial stewardship) was a key focus of ...
Breaking Medicine Technology:UHC Study: Variations in Use of Physician Preference Items Affect Patient Outcomes and Costs 2UHC Study: Variations in Use of Physician Preference Items Affect Patient Outcomes and Costs 3Uroplasty and Vision-Sciences Complete Merger 2Uroplasty and Vision-Sciences Complete Merger 3Uroplasty and Vision-Sciences Complete Merger 4Government of Canada hosts roundtable discussion to advance Canada's work on antimicrobial resistance 2Government of Canada hosts roundtable discussion to advance Canada's work on antimicrobial resistance 3Government of Canada hosts roundtable discussion to advance Canada's work on antimicrobial resistance 4
(Date:3/31/2015)... At Summit Breast Care, their passion is to provide ... caring manner. , Summit Breast Care has achieved national recognition ... cancer. They treat thousands of patients annually, not just ... Their doctors continue to be recognized as ‘Top Doctors’ ... Breast Care were planted in the mind and spirit of ...
(Date:3/31/2015)... Healthpointe’s team of hip ... their clinics. Specialties include hip dislocations, fractures, bursitis, sprains/strains, ... with hip injuries, Healthpointe has a renowned team of ... symptoms and underlying causes of the hip pain. Doctors ... future damage, while taking into consideration the patient’s athletic ...
(Date:3/31/2015)... 31, 2015 Dr. Uzma Parvez is having ... Dr. Parvez conducted Grand Grounds Presentations at St. Michael’s Medical ... Managing Side Effects”. The event was attended by a ... received very positive feedback from the Grand Rounds. It ... they’ve had in a while. , Ahead, Dr. Parvez ...
(Date:3/31/2015)... Researchers at UC Davis have ... how human livers heal. The difference centers on ... Normally, mouse PPARa is far more active and ... quickly regenerate damaged livers. However, the research shows ... boost the regenerative effects of human PPARa. The ...
(Date:3/31/2015)... Beckman Coulter is sponsoring a new educational ... Matter in Therapeutic Protein Injections”,” an educational session that will ... particles in liquids, with a focus on the challenges of ... attend and will be broadcast live April 8, 2015 at ... for protein-based materials, known as USP 787 , and ...
Breaking Medicine News(10 mins):Health News:Summit Breast Care is Celebrating Four Years as "NJ Top Docs" 2Health News:Healthpointe Now Treating Hip Dislocations, Hip Fractures, Hip Bursitis, and Hip Strains at Locations in Southern California 2Health News:NJ Top Docs Presents, Dr. Uzma Parvez of Total Pain Care 2Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 2Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 3Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 4Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 2Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 3
... medical colleges are set to open in Bihar as two ... in the health sector.// ,"The Bihar State Investment ... medical colleges in the private sector," said a state official ... of big private investments in the health sector," he added. ...
... mental hospitals around the country by British government to ... this year by// National Patient Safety Agency alleged that ... mentioned 19 incidents which caused ripples in the mental ... government. ,Mental Health director Louis Appleby have ...
... users, once infected with hepatitis C and battled off ... of the liver-killing virus according to a Canadian study.// ... British Columbia were tested by University of British Columbia ... of past infection. Drug users contract hepatitis C mainly ...
... Fund (Unicef) has announced the launch of a computer ... make better choices to combat diseases like AIDS.// ... in English and Swahili versions at unicef.org/voy/explore /aids/explore_1360.html, ... today, an online game that empowers young people to ...
... the eye cancer retinoblastoma has been developed by scientists ... a mouse model to cause a remarkable reduction in ... effects common with standard chemotherapy. In addition the treatment ... breast, lung, prostate and colon cancer, and is simple ...
... A global survey targeted to comprehend sexual behaviors of human ... sex in the present day are unfounded.// Monogamy is still ... of this survey are published in The Lancet. ... that people were in single relationships and the likelihood of ...
Cached Medicine News:Health News:Now A Computer Game To Battle AIDS 2Health News:Revolutionary Eye Cancer Treatment 2Health News:Revolutionary Eye Cancer Treatment 3Health News:Revolutionary Eye Cancer Treatment 4
Cilia Forceps, slanted jaws, gold plated....
Coaptation forceps. Insulated....
Semkin forceps with stops. Insulated....
Scoville-Greenwood bayonet forceps...
Medicine Products: